|
Issue |
Title |
|
Vol 35, No 5 (2025) |
Smoking-related interstitial fibrosis: radiographic morphological comparisons |
Abstract
PDF (Rus)
|
M. V. Samsonova, G. E. Baimakanova, I. Yu. Tarakanova, K. Yu. Mikhailichenko, A. L. Cherniaev |
|
Vol 35, No 5 (2025) |
Causes of hospitalization and their impact on the course of fibrosing interstitial lung diseases |
Abstract
PDF (Rus)
|
K. S. Ataman, S. Yu. Chikina, G. V. Nekludova, Z. M. Merzhoeva, S. N. Avdeev |
|
Vol 35, No 5 (2025) |
Efficacy of biologic therapy in patients with severe occupational and work-related asthma |
Abstract
PDF (Rus)
|
L. A. Shpagina, O. S. Kotova, I. S. Shpagin, G. V. Kuznetsova, S. A. Karmanovskaya, E. G. Kondyurina, V. V. Zelenskaya, N. V. Kamneva, V. A. Sergeev, K. Yu. Makarov |
|
Vol 35, No 5 (2025) |
The impact of occupational factors on the progressive course of interstitial lung diseases |
Abstract
PDF (Rus)
|
O. S. Vasilyeva, A. S. Belevskiy, N. Yu. Kravchenko, L. Ya. Frantsuzevich |
|
Vol 35, No 5 (2025) |
The condition of patients with sarcoidosis after their transition to IV X-ray stage |
Abstract
PDF (Rus)
|
A. A. Vizel, S. N. Avdeev, I. Yu. Vizel, G. R. Shakirova, L. A. Vizel |
|
Vol 35, No 5 (2025) |
Changes in the serum level of matrix metalloproteinases and surfactant proteins in patients with hypersensitivity pneumonitis |
Abstract
PDF (Rus)
|
E. V. Bolotova, Yu. G. Yurkova, I. V. Gilevich, L. V. Shul’zhenko |
|
Vol 35, No 4 (2025) |
Modern immunodiagnostics of tuberculosis infection in adults |
Abstract
PDF (Rus)
|
S. V. Smerdin, A. A. Gordeev, M. A. Plekhanova, M. V. Vershinina, A. P. Tkachuk, V. A. Manuylov, A. M. Kudryashova, B. S. Cherepovich, O. V. Borisova |
|
Vol 35, No 4 (2025) |
Association of bitter taste receptor TAS2R38 polymorphisms with smoking, asthma, functional and immunological abnormalities: a case–control study |
Abstract
PDF (Rus)
|
D. E. Naumov, O. O. Kotova, D. A. Gassan, E. G. Sheludko, E. Yu. Afanas’eva, A. V. Konev, Ju. M. Perelman |
|
Vol 35, No 4 (2025) |
The structure and gender characteristics of progressive pulmonary fibrosis according to retrospective research |
Abstract
PDF (Rus)
|
E. V. Bolotova, Yu. G. Yurkova, L. V. Shul’zhenko |
|
Vol 35, No 4 (2025) |
Peripheral blood monocyte level as a biomarker of pulmonary fibrosis severity – an unused opportunity for general clinical laboratory testing? |
Abstract
PDF (Rus)
|
E. I. Shchepikhin, S. A. Evdokimova, T. V. Beketova, T. R. Bagdasaryan, N. N. Vladimirova |
|
Vol 35, No 4 (2025) |
Age-related differences in the fractional exhaled nitric oxide concentration in patients with asthma |
Abstract
PDF (Rus)
|
M. A. Mokronosova, A. Yu. Konishcheva, S. A. Mazurina, T. M. Zheltikova |
|
Vol 35, No 4 (2025) |
Efficacy and safety of inhalation therapy with thermal heliumoxygen mixture in patients with exacerbation of chronic obstructive pulmonary disease complicated by hypoxemic and hypercapnic respiratory failure and secondary pulmonary arterial hypertension |
Abstract
PDF (Rus)
|
L. V. Shogenova |
|
Vol 35, No 4 (2025) |
Tuberculosis under the “mask” of coronavirus pneumonia during the decline of the COVID-19 pandemic |
Abstract
PDF (Rus)
|
E. V. Yakovleva, E. A. Borodulina, S. A. Zubakina, K. V. Zhilinskaya, E. S. Vdoushkina |
|
Vol 35, No 3 (2025) |
Efficacy of salbutamol and budesonide metered-dose inhaler in preventing exercise-induced bronchoconstriction in patients with mild asthma |
Abstract
PDF (Rus)
|
A. R. Dorotenko, M. S. Shustova, E. A. Orlova, M. V. Vershinina, A. B. Peskov, Yu. G. Schwartz, L. I. Sursiakova, R. T. Sardinov |
|
Vol 35, No 3 (2025) |
Efficacy and safety of the combined use of medical gases in patients with exacerbation of chronic obstructive pulmonary disease and secondary pulmonary arterial hypertension in the post-COVID period |
Abstract
PDF (Rus)
|
L. V. Shogenova |
|
Vol 35, No 3 (2025) |
Tolerability of inhaled mannitol in children with cystic fibrosis: initiation dose assessment |
Abstract
PDF (Rus)
|
A. V. Goryainova, S. Y. Semykin, L. S. Kazarova, N. Yu. Kashirskaya |
|
Vol 35, No 3 (2025) |
Pharmacoeconomic efficiency of using the drug budesonide+glycopyrronium bromide+formoterol for the supportive therapy of patients with COPD |
Abstract
PDF (Rus)
|
S. К. Zyryanov, Z. R. Aisanov, I. N. Dyakov |
|
Vol 35, No 3 (2025) |
Pharmacoeconomic efficiency of tezepelumab for the treatment of patients with severe asthma in the Russian Federation |
Abstract
PDF (Rus)
|
S. V. Nedogoda, S. N. Avdeev, A. S. Salasyuk, I. N. Barykina, V. O. Lutova, E. A. Popova |
|
Vol 35, No 3 (2025) |
Airway microbial landscape in patients with primary ciliary dyskinesia – a pilot study |
Abstract
PDF (Rus)
|
M. Yu. Chernukha, E. I. Kondratyeva, E. A. Domblides, L. R. Avetisyan, A. Yu. Voronkova, T. A. Kyian, V. G. Zhukhovitsky, N. B. Polyakov, E. I. Burtseva |
|
Vol 35, No 3 (2025) |
Comparison of spirometry results in adult patients with cystic fibrosis using different reference values |
Abstract
PDF (Rus)
|
A. V. Cherniak, M. Kh. Mustafina, S. A. Krasovskiy, Zh. K. Naumenko, S. Yu. Nistor, S. D. Gorbunkov, Ph. Yu. Kopylov |
|
Vol 35, No 2 (2025) |
Effect of polymorphic variants of genes involved in the phase I genes of xenobiotic biotransformation on the effectiveness and safety of therapy with CFTR modulators in cystic fibrosis with and without complications |
Abstract
PDF (Rus)
|
E. K. Zhekaite, Yu. L. Melyanovskaya, N. V. Balinova, E. V. Loshkova, A. Yu. Voronkova, E. I. Kondratyeva |
|
Vol 35, No 2 (2025) |
Targeted therapy in adult patients with cystic fibrosis: impact on the course of lower respiratory tract infections and the effectiveness of antibacterial treatment according to the registry of the Russian Federation |
Abstract
PDF (Rus)
|
E. L. Amelina, R. U. Kagazezhev, S. A. Krasovskiy, E. I. Kondratyeva, A. Yu. Voronkova, N. Yu. Kashirskaya, A. A. Korneev |
|
Vol 35, No 2 (2025) |
Adverse drug reactions during long-term use of two targeted drugs in pediatric patients with cystic fibrosis in the Russian Federation |
Abstract
PDF (Rus)
|
A. Yu. Voronkova, E. K. Zhekaite, I. R. Fatkhullina, O. I. Golubtsova, E. A. Enina, I. P. Karimova, M. V. Erzutova, A. V. Orlov, M. G. Rybalkina, T. I. Safonova, D. F. Sergienko, I. P. Shulyak, E. I. Kondratyeva |
|
Vol 35, No 2 (2025) |
Using elexacaftor/tezacaftor/ivacaftor + ivacaftor in preschool children with cystic fibrosis |
Abstract
PDF (Rus)
|
N. A. Ilyenkova, V. V. Chikunov, S. A. Shive |
|
Vol 35, No 2 (2025) |
Results of neonatal screening for cystic fibrosis (18-year follow-up) |
Abstract
PDF (Rus)
|
I. R. Fatkhullina, E. I. Kondratyeva, N. D. Odinaeva, A. Yu. Voronkova, E. K. Zhekaite, S. V. Voronin, S. I. Kutsev |
|
Vol 35, No 2 (2025) |
A comprehensive study of a rare pathogenic CFTR gene variant G1047S in two siblings |
Abstract
PDF (Rus)
|
D. O. Mokrousova, A. S. Efremova, Yu. L. Melyanovskaya, A. Yu. Voronkova, S. A. Krasovskiy, M. G. Krasnova, N. V. Rassomahina, T. B. Bukharova, O. V. Makhnach, D. V. Goldshtein, E. I. Kondratyeva |
|
Vol 35, No 1 (2025) |
High-dose inhaled nitric oxide therapy for nosocomial pneumonia following cardiac surgical procedures |
Abstract
PDF (Rus)
|
T. P. Kalashnikova, N. O. Kamenshchikov, Yu. K. Podoksenov, Yu. A. Arseneva, M. A. Tyo, E. A. Churilina, Yu. S. Svirko, S. N. Avdeev, B. N. Kozlov, A. A. Boshchenko |
|
Vol 35, No 1 (2025) |
Impulse oscillometry parameters and diffusing capacity of the lung in patients with pulmonary tuberculosis: is there an inter-relationship? |
Abstract
PDF (Rus)
|
L. D. Kiryukhina, E. V. Kokorina, P. K. Yablonskiy |
|
Vol 35, No 1 (2025) |
Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19 |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S. N. Feygelman |
|
Vol 35, No 1 (2025) |
Comprehensive evaluation of the respiratory system, cardiovascular system, and psychoemotional disorders in post-COVID-19 adult patients |
Abstract
PDF (Rus)
|
Kh. S. Delmaeva, N. V. Mukhina, I. S. Komarova, G. V. Nekludova, A. A. Metalnickov, S. N. Avdeev, S. A. Rachina, A. A. Sokolov, N. A. Ananicheva, S. S. Mirzakhamidova |
|
Vol 34, No 6 (2024) |
Registry as a tool for monitoring effectiveness of immunobiological therapy for severe asthma in real clinical practice |
Abstract
PDF (Rus)
|
V. V. Naumova, D. V. Kiseleva, K. A. Zykov, Е. К. Beltyukov, E. S. Klyachina, I. O. Nikiforova, P. A. Suvorkov |
|
Vol 34, No 6 (2024) |
Analysis of the incidence, disability and mortality rates of the Russian population due to respiratory diseases and COVID-19 in the period 2016 – 2021 |
Abstract
PDF (Rus)
|
E. V. Bystritskaya, T. N. Bilichenko, V. M. Misharin |
|
Vol 34, No 6 (2024) |
Analysis of the relationship between the serum lipopolysaccharide level and other inflammation markers, clinical and functional characteristics of patients with COPD without exacerbation |
Abstract
PDF (Rus)
|
M. I. Smirnova, D. N. Antipushina, A. S. Kurekhyan, N. G. Gumanova, Ya. N. Koshelyaevskaya, V. A. Metelskaya, N. L. Bogdanova, M. S. Pokrovskaya, O. A. Litinskaya, A. V. Kontsevaya, O. M. Drapkina, V. V. Makarov, S. M. Yudin |
|
Vol 34, No 6 (2024) |
Clinical features of chronic obstructive pulmonary disease in patients with pulmonary tuberculosis and HIV infection |
Abstract
PDF (Rus)
|
H. Tlais, E. Kh. Anaev, N. P. Kniajeskaia, S. P. Shchelykalina, A. S. Belevskiy |
|
Vol 34, No 6 (2024) |
Phagocytic activity of leukocytes in patients with COVID-19 |
Abstract
PDF (Rus)
|
M. P. Kostinov, V. V. Gainitdinova, V. V. Osiptsov, I. V. Bisheva, S. A. Skhodova, E. A. Khromova, I. A. Baranova, N. O. Kryukova, E. S. Sokolova, A. G. Chuchalin |
|
Vol 34, No 6 (2024) |
Therapeutic effect of CFTR modulators in cystic fibrosis patients with the 2789+5G>A splice variant in the genotype |
Abstract
PDF (Rus)
|
M. G. Krasnova, A. S. Efremova, Yu. L. Melyanovskaya, S. A. Krasovskiy, D. O. Mokrousova, T. B. Bukharova, N. V. Bulatenko, E. I. Kondratyeva, D. V. Goldshtein |
|
Vol 34, No 5 (2024) |
Chronic obstructive pulmonary disease and its treatment in the Russian Federation: Results of a cross-sectional assessment from the CORSAIR observational study |
Abstract
PDF (Rus)
|
V. V. Arkhipov, S. N. Avdeev, V. I. Trofimov, G. L. Osipova, E. M. Vishneva, О. A. Shangina, N. A. Kirillova, Т. A. Lagutina, E. I. Van’kova, I. A. Shipilova, J. M. Ilkovich, О. Y. Ananeva |
|
Vol 34, No 5 (2024) |
Intrapulmonary electronic auscultation for asthma and chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
S. I. Glotov, O. M. Uryasev, Yu. Yu. Byalovskiy, S. V. Bulatetskiy, I. B. Ponomareva |
|
Vol 34, No 5 (2024) |
24-hour arterial stiffness profile in asthma patients with obesity |
Abstract
PDF (Rus)
|
N. A. Karoli, O. T. Zarmanbetova |
|
Vol 34, No 4 (2024) |
Characteristics of patients with sarcoidosis that was diagnosed using invasive methods |
Abstract
PDF (Rus)
|
E. A. Borodulina, S. Yu. Pushkin, E. V. Yakovleva, D. V. Lyukshin, E. I. Povalyaev |
|
Vol 34, No 4 (2024) |
Results of analysis of the sarcoidosis registry of the Republic of Tatarstan |
Abstract
PDF (Rus)
|
A. A. Vizel, S. N. Avdeev, I. Yu. Vizel, G. R. Shakirova, E. Z. Kudryavtseva, R. I. Shaymuratov, A. V. Tikhonov, A. R. Abashev, L. A. Vizel |
|
Vol 34, No 4 (2024) |
Misdiagnosis of interstitial lung diseases according to the register of Irkutsk |
Abstract
PDF (Rus)
|
I. N. Trofimenko, M. S. Nashatyreva, B. A. Chernyak |
|
Vol 34, No 4 (2024) |
Clinical experience with ciclesonide as maintenance treatment for not-well controlled mild and moderate asthma in adolescents |
Abstract
PDF (Rus)
|
A. V. Kamaev, Yu. B. Klyukhina, O. V. Trusova |
|
Vol 34, No 4 (2024) |
Tolerability of the first inhaled mannitol dose in children with cystic fibrosis |
Abstract
PDF (Rus)
|
V. V. Shadrina, E. K. Zhekaite, A. Yu. Voronkova, V. D. Sherman, Yu. A. Kondakova, Yu. S. Pinegina, A. A. Poloyko, E. G. Furman, E. I. Kondratyeva |
|
Vol 34, No 3 (2024) |
Efficacy and safety of high doses of inhaled nitric oxide in patients with community-acquired pneumonia: a pilot study |
Abstract
PDF (Rus)
|
N. A. Tsareva, G. V. Nekludova, A. I. Yaroshetskiy, G. S. Nuralieva, F. T. Kurkieva, A. E. Shmidt, O. A. Suvorova, A. V. Goroshkov, K. S. Ataman, I. S. Avdeev, Z. M. Merzhoeva, N. V. Trushenko, S. N. Avdeev |
|
Vol 34, No 3 (2024) |
Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia |
Abstract
PDF (Rus)
|
D. S. Fomina, G. L. Ignatova, T. G. Kabanova, A. A. Kameleva, L. S. Kozyreva, N. I. Kosyakova, L. M. Kudelya, N. A. Kuzubova, I. V. Leshсhenko, L. V. Shulzhenko |
|
Vol 34, No 3 (2024) |
The burden of severe exacerbations, their relationship to clinical outcomes and the use of health resources in the Russian population of patients with chronic obstructive pulmonary disease: a subanalysis of the Russian population of EXACOS International Study |
Abstract
PDF (Rus)
|
S. N. Avdeev, I. V. Leshchenko, G. V. Ignatova, V. N. Antonov, N. E. Kostina, E. U. Kochegarova, A. I. Aristov, N. V. Trushenko, S. Yu. Chikina, G. S. Nuralieva, N. V. Popova, D. A. Svirido, S. V. Skal’skiy, D. A. Tikhanov, E. L. Tikhonovich |
|
Vol 34, No 2 (2024) |
Comparative characteristics of patients with primary ciliary dyskinesia with or without Kartagener’s syndrome |
Abstract
PDF (Rus)
|
E. I. Kondratyeva, S. N. Avdeev, T. A. Kyian, Z. M. Merzhoeva, O. A. Karpova, E. E. Bragina, O. P. Ryzhkova, V. M. Popova, M. A. Starinova, V. B. Chernykh |
|
Vol 34, No 2 (2024) |
Results of a prospective open observational study of the use of dornase alfa as part of complex therapy for patients with cystic fibrosis |
Abstract
PDF (Rus)
|
V. V. Shadrina, E. I. Kondratyeva, A. Yu. Voronkova, E. K. Zhekaite, S. A. Krasovskiy, E. L. Amelina, A. V. Orlov, Yu. S. Pinegina, A. E. Lavrova, S. V. Trishina, D. I. Abdulganieva, S. Yu. Semykin, A. V. Vlasova |
|
Vol 34, No 2 (2024) |
A new software for automated analysis of respiratory tract ciliary epithelium movement for the diagnosis of primary ciliary dyskinesia |
Abstract
PDF (Rus)
|
T. A. Kyian, S. A. Smirnikhina, A. G. Demchenko, R. V. Veiko, E. I. Kondratyeva |
|
Vol 34, No 2 (2024) |
Parallels between clinical and genetic characteristics in children with primary ciliary dyskinesia |
Abstract
PDF (Rus)
|
A. A. Novak, Yu. L. Mizernitskiy |
|
Vol 34, No 2 (2024) |
Efficacy and safety of triple therapy (elexacaftor/tezacaftor/ ivacaftor) in children with cystic fibrosis: 12-month follow-up |
Abstract
PDF (Rus)
|
E. I. Kondratyeva, N. D. Odinaeva, E. V. Repjeva, I. R. Fatkhullina, V. D. Sherman |
|
Vol 34, No 1 (2024) |
Effect of hydrogen inhalation on cardiovascular and interstitial components of pulmonary hypertension in rats |
Abstract
PDF (Rus)
|
T. A. Kuropatkina, K. F. Gufranov, F. Yu. Sychev, M. M. Artemieva, G. N. Bondarenko, D. I. Esaulenko, T. V. Samoylenko, V. V. Shyshkina, N. A. Medvedeva, O. S. Medvedev |
|
Vol 34, No 1 (2024) |
The first experience of the combined use of nitric oxide and molecular hydrogen for cardiac surgery in high-risk patients |
Abstract
PDF (Rus)
|
V. V. Pichugin, A. V. Deryugina, S. E. Domnin, A. S. Shirshin, S. A. Fedorov, S. N. Buranov, S. A. Jourko, M. V. Ryazanov, Yu. D. Brichkin, D. A. Danilova |
|
Vol 34, No 1 (2024) |
Combination therapy with medical gases (nitric oxide and molecular hydrogen): safety assessment |
Abstract
PDF (Rus)
|
D. D. Pozdnyakova, I. A. Baranova, V. D. Selemir, A. G. Chuchalin |
|
Vol 33, No 6 (2023) |
Efficacy of treatment of chronic obstructive pulmonary disease after virus-induced exacerbations |
Abstract
PDF (Rus)
|
L. A. Shpagina, O. S. Kotova, I. S. Shpagin, G. V. Kuznetsova, S. A. Karmanovskaya, L. A. Panacheva, E. V. Anikina |
|
Vol 33, No 6 (2023) |
Ten-year analysis of the efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
G. L. Ignatova, S. N. Avdeev, V. N. Antonov, E. V. Blinova |
|
Vol 33, No 6 (2023) |
Post-COVID syndrome and capillary bed abnormalities detected by videocapillaroscopy |
Abstract
PDF (Rus)
|
H. C. Nguyen, A. G. Chuchalin |
|
Vol 33, No 6 (2023) |
Using generic drug elexacaftor/tezacaftor/ivacaftor+ ivacaftor in patients with cystic fidosis in routine clinical practice |
Abstract
PDF (Rus)
|
S. A. Krasovskiy, R. U. Kagazezhev |
|
Vol 33, No 6 (2023) |
The macrostructure of lungs on multislice computed tomography scans in the long-term period after COVID-19 pneumonia |
Abstract
PDF (Rus)
|
P. M. Kotlyarov, D. G. Soldatov, I. D. Lagkueva, Z. S. Tsallagova, V. A. Solodkiy |
|
Vol 34, No 1 (2024) |
Lymphangioleiomyomatosis: X-ray morphological comparisons |
Abstract
PDF (Rus)
|
M. V. Samsonova, A. S. Timofeeva, P. V. Pakhomov, E. S. Pershina, A. L. Cherniaev, M. A. Makarova, A. V. Cherniak |
|
Vol 33, No 5 (2023) |
Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression |
Abstract
PDF (Rus)
|
D. S. Fomina, S. S. Andreev, G. V. Andrenova, T. S. Kruglova, D. M. Demidchik, O. S. Kovalevskaya, Z. Yu. Mutovina, E. A. Dokukina, O. V. Filon, A. V. Petkova, E. K. Khanonina, M. Yu. Samsonov |
|
Vol 33, No 5 (2023) |
Frailty phenotype in chronic obstructive pulmonary disease patients: prevalence and relation to disease severity |
Abstract
PDF (Eng)
|
H. W. Abdelwahab, H. M. Shata, D. A. Abdelghany, M. O. Elmaria |
|
Vol 33, No 5 (2023) |
Impact of biologicals on chronic rhinosinusitis with nasal polyps in combination with severe asthma |
Abstract
PDF (Rus)
|
D. O. Timoshenko, K. S. Pavlova, O. M. Kurbacheva, M. E. Dyneva, N. I. Ilina, I. P. Shilovskiy, A. S. Dvornikov, M. R. Khaitov |
|
Vol 33, No 5 (2023) |
Course of sarcoidosis in patients treated with systemic corticosteroids |
Abstract
PDF (Rus)
|
A. A. Vizel, S. N. Avdeev, I. Yu. Vizel, G. R. Shakirova, A. E. Vlasenko |
|
Vol 33, No 5 (2023) |
Composition of bacterial microbiome in sputum of patients with localized forms of pulmonary tuberculosis |
Abstract
PDF (Rus)
|
V. G. Druzhinin, E. D. Baranova, P. S. Demenkov, Ju. V. Zakharova, M. B. Lavryashina, A. V. Larionov, L. V. Matskova, A. V. Shabaldin, T. V. Pyanzova |
|
Vol 33, No 5 (2023) |
Dynamics of functional changes in the respiratory system after COVID-19-associated lung injury at one year after hospital discharge |
Abstract
PDF (Rus)
|
A. V. Chernyak, M. Kh. Mustafina, Zh. K. Naumenko, E. N. Kalmanova, K. A. Zykov |
|
Vol 33, No 4 (2023) |
Using colistimethate sodium in complex therapy of cystic fibrosis in children under 6 years of age |
Abstract
PDF (Rus)
|
N. V. Petrova, O. I. Simonova, L. S. Gordeev, C. G. Anai-ool, E. A. Samoilova |
|
Vol 33, No 4 (2023) |
Therapy of gram-negative infection in the complex treatment of cystic fibrosis |
Abstract
PDF (Rus)
|
A. Yu. Voronkova, E. K. Zhekaite, V. D. Sherman, E. L. Amelina, A. V. Orlov, O. V. Usacheva, V. V. Tarakanova, L. V. Smirnova, E. V. Pasnova, N. D. Odinaeva, E. I. Kondratyeva |
|
Vol 33, No 3 (2023) |
The role of nonspecific proteolysis in the development of alterative changes in lung tissue when using electronic cigarettes |
Abstract
PDF (Rus)
|
L. L. Aliyev, M. A. Aliyev, P. E. Maximova, T. P. Makalish, A. V. Kubyshkin, E. Yu. Zyablitskaya, A. V. Grigoryants, Ya. Karyophyllidis, D. I. Mitrushkin |
|
Vol 33, No 3 (2023) |
The influence of the genotype and respiratory tract microflora on lung function and nutritional status in adult cystic fibrosis patients in long-term follow-up |
Abstract
PDF (Rus)
|
O. N. Titova, V. R. Makhmutova, T. E. Gembitskaya, A. G. Chermensky, T. A. Stepanenko, N. A. Shklyarevich |
|
Vol 33, No 3 (2023) |
Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia |
Abstract
PDF (Rus)
|
D. S. Fomina, G. L. Ignatova, T. G. Kabanova, A. A. Kameleva, L. S. Kozyreva, N. I. Kosyakova, L. M. Kudelya, N. A. Kuzubova, I. V. Leshсhenko, O. A. Mukhina, L. V. Shulzhenko |
|
Vol 33, No 3 (2023) |
Features of clinical and morphological manifestations of pneumonia complicated by exudative pleuritis in senile patients |
Abstract
PDF (Rus)
|
N. A. Stogova |
|
Vol 33, No 3 (2023) |
Urgent intraoperative cytological diagnosis of spherical mass lesions in the lungs |
Abstract
PDF (Rus)
|
I. A. Kruglova, T. V. Paranina, S. V. Zinoviev, O. V. Utkin, A. N. Denisenko |
|
Vol 33, No 4 (2023) |
Mixed bacterial-viral lung infections in patients with cystic fibrosis |
Abstract
PDF (Rus)
|
E. M. Burmistrov, K. G. Krasnoslobodtsev, L. R. Avetisyan, E. A. Siyanova, O. S. Medvedeva, E. G. Tselikina, N. B. Polyakov, A. I. Solovyev, A. Yu. Voronkova, E. I. Kondratyeva, S. A. Krasovskiy, V. G. Zhukhovitsky, E. I. Burtseva, N. A. Nikitenko, M. Yu. Chernukha |
|
Vol 33, No 4 (2023) |
Impact of early tocilizumab administration on the progression of respiratory failure in COVID-19 patients |
Abstract
PDF (Rus)
|
Z. M. Merzhoeva, A. I. Yaroshetskiy, S. A. Savko, A. P. Krasnoshchekova, I. A. Mandel, N. A. Tsareva, N. V. Trushenko, G. S. Nuralieva, S. N. Avdeev |
|
Vol 33, No 4 (2023) |
Assessment of long-term clinical and functional changes in patients recovering from severe COVID-19-associated lung damage |
Abstract
PDF (Rus)
|
G. B. Abdullaeva, S. N. Avdeev, E. V. Fominykh, G. S. Gordina, M. Kh. Mustafina |
|
Vol 33, No 2 (2023) |
Characteristics of patients with primary ciliary dyskinesia |
Abstract
PDF (Rus)
|
E. D. Nikolaeva, D. Yu. Ovsyannikov, V. A. Strel’nikova, D. P. Polyakov, T. V. Tronza, O. A. Karpova, I. R. Fatkhullina, Е. E. Bragina, O. A. Shchagina, M. A. Starinova, S. А. Krasovskiy, T. A. Kyian, E. K. Zhekaite |
|
Vol 33, No 2 (2023) |
Russian registry of patients with cystic fibrosis: lessons and perspectives |
Abstract
PDF (Rus)
|
E. I. Kondratyeva, A. Yu. Voronkova, N. Yu. Kashirskaya, S. A. Krasovsky, M. A. Starinova, E. L. Amelina, S. N. Avdeev, S. I. Kutsev |
|
Vol 33, No 2 (2023) |
Efficacy of CFTR modulators in clinical practice (6-month follow-up) |
Abstract
PDF (Rus)
|
E. I. Kondratyeva, N. D. Odinaeva, E. K. Zhekaite, E. V. Pasnova, I. R. Fatkhullina, T. Yu. Maksimycheva, V. D. Sherman, S. I. Kutsev |
|
Vol 33, No 2 (2023) |
Function of ion channels of epithelial cells in cystic fibrosis |
Abstract
PDF (Rus)
|
Yu. L. Melyanovskaya, E. I. Kondratyeva, A. M. Budaeva |
|
Vol 33, No 1 (2023) |
Metalloproteinases as biomarkers of chronic obstructive pulmonary disease progression |
Abstract
PDF (Rus)
|
O. A. Tsvetkova, O. O. Voronkova, O. E. Buyanova, A. O. Dubinin |
|
Vol 33, No 1 (2023) |
The role of mast cells and their proteases in lung damage associated with COVID-19 |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, V. V. Shishkina, D. I. Esaulenko, A. A. Filin, I. A. Savushkina, Inna M. Perveeva, N. G. Alekseeva |
|
Vol 33, No 1 (2023) |
The inspiratory activity of respiratory center and respiratory muscles strength after COVID-19 |
Abstract
PDF (Rus)
|
O. I. Savushkina, A. A. Zaicev, E. V Kryukov, P. A Astanin, N. A Aseeva, M. M. Malashenko, O. V. Fesenko |
|
Vol 33, No 1 (2023) |
Bronchodilator therapy in patients with chronic obstructive pulmonary disease: what should be considered in clinical practice when choosing a dosing regimen? |
Abstract
PDF (Rus)
|
O. N. Titova, N. A. Kuzubova, A. G. Kozyrev, A. A. Shumilov |
|
Vol 33, No 1 (2023) |
Efficacy and safety of bovhyaluronidase azoximer (Longidase) in patients with post-COVID syndrome: results of an open, prospective, controlled, comparative, multicenter clinical trial DISSOLVE |
Abstract
PDF (Rus)
|
A. G. Chuchalin, P. K. Yablonskiy, T. V. Rubanik, O. A. Chernyavskaya, V. V. Naumov, L. I. Korneva, L. M. Kudelуa, A. Yu. Petukhova, O. V. Masalkina, Yu. V. Argamakova, G. L. Ignatova, A. G. Borisov, T. R. Kasyanova, A. K. Suleymanova |
|
Vol 33, No 4 (2023) |
Changes in mortality rates and hospital mortality associated with bronchial asthma in the population of the Russian Federation (2014 – 2018) |
Abstract
PDF (Rus)
|
E. V. Bystritskaya, T. N. Bilichenko |
|
Vol 32, No 6 (2022) |
Chronic obstructive pulmonary disease and miocardial revascularisation outcomes: relationship with self-reported quality of life |
Abstract
PDF (Rus)
|
O. V. Kamenskaya, I. Yu. Loginova, A. S. Klinkova, S. S. Porotnikova, V. N. Lomivorotov, V. V. Lomivorotov, A. M. Cherniavsky |
|
Vol 32, No 6 (2022) |
Analysis of the effectiveness of smoking cessation in patients with pulmonary tuberculosis in a hospital setting |
Abstract
PDF (Rus)
|
N. V. Chumovatov, N. S. Antonov, G. M. Sakharova, N. A. Chernyh, V. V. Romanov, A. Е. Ergeshov, L. I. Rusakova |
|
Vol 32, No 6 (2022) |
Hyaluronic acid as a predictor of exacerbation of occupational chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
V. D. Fedotov, A. C. Khlystov, T. V. Blinova, L. A. Strakhova, N. A. Lavrenyuk, I. S. Dobrotina |
|
Vol 32, No 6 (2022) |
The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio in prediction of COVID-19 outcome |
Abstract
PDF (Eng)
|
L. Suliman, M. Elwasefy, N. S. Farrag, H. A. Tawab, H. W. Abdelwahab |
|
Vol 32, No 6 (2022) |
Spectral analysis of cough sounds of patients with COVID-19 |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S. N. Feygelman, O. N. Choporov, A. V. Maximov, A. V. Pertsev |
|
Vol 32, No 6 (2022) |
The clinical course of chronic thromboembolic pulmonary hypertension after COVID-19 |
Abstract
PDF (Rus)
|
Z. S. Valieva, M. K. Barkovskaya, A. A. Tkacheva, T. V. Martynyuk |
|
No 4 (2001) |
Latex allergy in medical workers |
Abstract
PDF (Rus)
|
A. G. Chuchalin, O. S. Vasilieva, G. A. Kazakova, G. L. Osipova, A. A. Babakhin |
|
No 4 (2001) |
Ultrastructural ciliar lesions in primary ciliar dyskinesia |
Abstract
PDF (Rus)
|
M. Ebsen, K. Morgenrot |
|
No 4 (2001) |
Lung carcinoma in persons lived for long time at radioactive contaminated territories of Semipalatinsk region (Kazakhstan) |
Abstract
PDF (Rus)
|
E. A. Kogan, G. S. Sagindikova, S. M. Sekamova, G. Jak, L. Sh. Redzhabaeva |
|
No 4 (2001) |
Cystic fibrosis in adult patients: cardiac and respiratory function |
Abstract
PDF (Rus)
|
J. K. Naumenko, A. V. Cherniak, E. L. Amelina, G. V. Nekludova, E. N. Kalmanova, A. G. Chuchalin |
|
No 4 (2001) |
Inhaled nitric oxide in primary pulmonary hypertension: effects on pulmonary haemodynamics, gas exchange and oxygen transport |
Abstract
PDF (Rus)
|
S. N. Avdeev, N. A. Tsareva, G. V. Nekludova, I. E. Chazova, A. G. Chuchalin |
|
No 4 (2001) |
Drug-resistant lung tuberculosis: diagnosis and management |
Abstract
PDF (Rus)
|
V. Yu. Mishin |
|
No 4 (2001) |
Laser therapy in treatment and rehabilitation of lung tuberculosis |
Abstract
PDF (Rus)
|
N. A. Zhuk, E. E. Kalinina, M. V. Levchenko |
|
No 4 (2001) |
DOTS strategy is a way to rapid recovery of new diagnosed lung tuberculosis patients in Russia |
Abstract
PDF (Rus)
|
A. K. Strelis, G. V. Yanova, G. G. Peremitin, V. V. Polivakho, L. E. Petrova, A. A. Platonenkova, S. G. Shvedova, E. V. Nekrasova, A. A. Strelis, L. N. Buinova, O. V. Filinyuk |
|
No 4 (2001) |
New abilities in treatment of bronchoobstructive syndrome in children |
Abstract
PDF (Rus)
|
A. B. Malakhov, S. A. Makarova, M. A. Malakhov, V. S. Malyshev, N. A. Sellverstova |
|
No 4 (2001) |
Pathogenic basis for application of fenspirid (erespal) in bronchial asthma children |
Abstract
PDF (Rus)
|
S. V. Lukjanov, A. S. Dukhanin, E. V. Sereda, O. F. Lukina, Yu. B. Belousov |
|
No 4 (2001) |
Malignant pleural mesotheliomas |
Abstract
PDF (Rus)
|
Е. М. Nepomnyashchaya, S.J.-P. Bosenko |
|
No 4 (2001) |
Topic bacterial lysates in immune rehabilitation of children with anti-infectious defence disorders |
Abstract
PDF (Rus)
|
I. A. Tusankina, E. V. VIasov, S. A. Kargapolov, V. N. Pisklakova, V. N. Shershnev |
|
No 3 (2001) |
Phenotypical and immunological features in obligate heterozigotes of cystic fibrosis (CF) gene |
Abstract
PDF (Rus)
|
T. E. Guembitskaya, М. A. Petrova, Е. А. Kuprina, O. V. Voronina |
|
No 3 (2001) |
The results of implementation of GINA guide-lines into the public health practice (Six-year antiasthmatic program in Smolensk city) |
Abstract
PDF (Rus)
|
A. A. Punin, V. I. Starovoytov, S. V. Kovaleva, R . S. Bogachev |
|
No 3 (2001) |
Efficacy of long-term therapy of chronic obstructive bronchitis |
Abstract
PDF (Rus)
|
S. S. Yakushin, E. A. Smirnova, K. S. Yakushin |
|
No 3 (2001) |
Ten years of molecular genetic diagnosis of cystic fibrosis in Russian patients |
Abstract
PDF (Rus)
|
N. V. Petrova, E. K. Ginter |
|
No 3 (2001) |
Medical and social provision of cystic fibrosis patients |
Abstract
PDF (Rus)
|
Z. A. BIistinova, V. A. Proshin, N. I. Kapranov, N. Yu. Kashirskaya |
|
No 3 (2001) |
Bioelectric properties of respiratory epithelium in cystic fibrosis patients |
Abstract
PDF (Rus)
|
E. N. Mitkina, T. E. Gembitskaya, L. A. Zhelenina, A. G. Chermensky, A. V. Orlov, E. K. Dotsenko |
|
No 3 (2001) |
An experience of intravenous antibacterial therapy at home in cystic fibrosis children |
Abstract
PDF (Rus)
|
I. A. Osipova, Z. A. BIistinov, A. N. Kaprano, S. V. Pyatova |
|
No 3 (2001) |
Cough: aetiology, natural history, diagnosis, therapy |
Abstract
PDF (Rus)
|
I. G. Danilyak |
|
No 3 (2001) |
Microbiological aspects of etiology and antimicrobial therapy of bronchopulmonary infection in cystic fibrosis adults |
Abstract
PDF (Rus)
|
М. N. Zubkov, V. A. Samoylenko, E. N. Gugunidze, A. G. Shushalin |
|
No 3 (2001) |
Longterm low-dose therapy with macrolides in cystic fibrosis |
Abstract
PDF (Rus)
|
T. V. Lubskaya, N. I. Kapranov, N. J. Kashirskaya, L. A. Shabalova, A. L. Pukhatsky, G. V. Shmarina, S. N. Kokarovtseva |
|
No 3 (2001) |
Nimesulide in cystic fibrosis treatment |
Abstract
PDF (Rus)
|
A. L. Pukhalsky, L. A. Shabalova, G. V. Shmarina, N. I. Kapranov, S. I. Kokarovtseva |
|
No 3 (2001) |
Bleeding from the gastrointestinal tract in cystic fibrosis patients with liver cirrhosis and portal hypertension |
Abstract
PDF (Rus)
|
M. N. Sukhov, N. I. Kapranov, N. Yu. Kashirskaya, A. V. Drozdov, A. V. Kobiatsky, S. Yu. Semykin, T. Yu. Kapustina |
|
No 3 (2001) |
Study of the ciliary epitelium function in the patients with CF and COPD by lifetime television microscopy |
Abstract
PDF (Rus)
|
A. G. Tchermensky, T. E. Gembitskaya, T. S. Sologub, A. V. Orlov, E. N. Mitkina, L. A. Jelenina, M. E. Faustova, V. V. Shabalin |
|
No 3 (2001) |
Diagnostic meaning of indirect method for elastasa-1 pancreatic failure detection in faecal material of cystic fibrosis patients |
Abstract
PDF (Rus)
|
N. Yu. Kashirskaya, N. I. Kapranov, N. F. Kabanova, E. A. Kalashnikova |
|
No 3 (2001) |
Cystic fibrosis: current survival |
Abstract
PDF (Rus)
|
E. L. Amelina, A. V. Cherniak, A. L. Cherniaev |
|
No 2 (2001) |
Some aspects of therapyresistance in patients with, atopic moderate-to-severe asthma |
Abstract
PDF (Rus)
|
L. M. Ogorodova, O. S. Kobyakova, F. I. Petrovsky, F. l. Abazova, Yu. A. Petrovskaya, A. V. Salnikov |
|
No 2 (2001) |
Inhaled corticosteroids (Pulmicort) for nebulized therapy of children |
Abstract
PDF (Rus)
|
N. A. Geppe, N. A. Seliverstova, A. B. Malakhov, M. N. Lisitsin, M. N. Snegotskaya, V. S. Malyshev |
|
No 2 (2001) |
An experience of long-term use of Erespal in chronic obstructive bronchitis patients |
Abstract
PDF (Rus)
|
A. V. Beilepko |
|
No 2 (2001) |
Changes of humoral and secretory defending factors against immunotherapy of children being frequently ill |
Abstract
PDF (Rus)
|
A. V. Karaulov, E. V. Klimov |
|
No 2 (2001) |
Chronic obstructive lung disease and ischaemic heart disease: some aspects of functional diagnostics |
Abstract
PDF (Rus)
|
L. I. Kozlova |
|
No 2 (2001) |
Changes of endothelium functional status in bronchial asthma patients under the therapy with angiotensin-converting factor inhibitors |
Abstract
PDF (Rus)
|
N. A. Karoli, A. P. Rebrov |
|
No 2 (2001) |
An influence of bronchoobstructive syndrome on parameters of arterial blood pressure daily monitoring |
Abstract
PDF (Rus)
|
L. I. OIbinskaya, A. A. Belov, O. A. Tsvetkova, N. A. Lakshina |
|
No 2 (2001) |
Opportunities for life expectancy prognosis to specify indications for lung transplantation in IFA patients |
Abstract
PDF (Rus)
|
T. A. Fedorova, P. K. Yablonsky, A. L. Bulyanina, N. I. Alexandrova, M. M. IIkovich, L. N. Novikova, E. V. Simonenko, T. A. Stepanenko |
|
No 2 (2001) |
Clinical aspects of outpatient rehabilitation of respiratory patients |
Abstract
PDF (Rus)
|
N. A. Zhuk, E. E. Kalinina, L. G. Tsukanova, N. F. Mudrik |
|
No 2 (2001) |
Colour identification of normal black-and-white chest radiograms |
Abstract
PDF (Rus)
|
N. V. Afanasova, V. A. Degtyarev, M. A. Kaplan, V. V. Pavlov, S. V. Shakhtarin, L. S. Borisova |
|
No 2 (2001) |
Sleep respiratory disorders in congestive heart failure patients |
Abstract
PDF (Rus)
|
I. M. Voronin, A. M. Belov, A. G. Chuchalin |
|
No 2 (2001) |
Natural history of experimental dust bronchitis |
Abstract
PDF (Rus)
|
l. V. Dvorakovskaya, L. N. Danilov, B. G. Lisochkin, E. S. Lebedeva, G. P. Orlova, M. E. Malyshev |
|
No 2 (2001) |
Bronchial asthma prevalence at Sverdlovsk region |
Abstract
PDF (Rus)
|
I. V. Leshchenko |
|
No 2 (2001) |
Bronchial asthma prevalence in Uzbekistan |
Abstract
PDF (Rus)
|
A. M. Ubaidullaev, G. T. Uzakova |
|
No 2 (2001) |
Evaluation of conservative and operative treatment of lung abscesses considering immune disorders |
Abstract
PDF (Rus)
|
V. T. Radomsky, E. V. Radomsky |
|
No 2 (2001) |
Cell reactions in the lungs of patients with chronic respiratory diseases exacerbations |
Abstract
PDF (Rus)
|
O. P. Makarova, L. N. Shishkina, A. P. Ogirenko, S. M. Nasonova, S. G. Chuvakin |
|
No 1 (2001) |
An assessment of clinical efficacy of Halixol in a complex therapy of chronic obstructive and bronchial asthma patients |
Abstract
PDF (Rus)
|
S. I. Ovcharenko, E. V. Malov, O. A. Peredelskay |
|
No 1 (2001) |
An influence of the local immune corrector IRS 19 with vaccine properties on hydrogen peroxide concentration and myeloperoxidase activity in nasal washes from chronic bronchitis patients |
Abstract
PDF (Rus)
|
Dariusz Nowak, Michal Prozynski, Tadeusch Pietras, Robert Stolarek, Piotr Mazerant, Michal Leder |
|
No 1 (2001) |
Foradil and its place in bronchial asthma therapy |
Abstract
PDF (Rus)
|
E. N. Kalmanova, Z. R. Aisanov |
|
No 1 (2001) |
Pharmacoeconomic aspects of sodium nedocromil application in adults and children with bronchial asthma |
Abstract
PDF (Rus)
|
N. A. Geppe, I. V. Grebeneva, S. I. Erdes, N. D. Digilova, V. P. Komarova |
|
No 1 (2001) |
A ground for differentiated application of non-specific pathogenic medications in a complex therapy of lung tuberculosis patients |
Abstract
PDF (Rus)
|
E. V. Starostenko, R. P. Selitskaya, A. M. Salpagarov, A. S. Ivanova, Yu. Yu. Ponomaryova, R. E. Beresneva, O. N. Sumenkova, O. A. Kosareva |
|
No 1 (2001) |
Orientation of tuberculosis patients to recovery using educational programme of «Phtysa-school» |
Abstract
PDF (Rus)
|
E. V. Gnezdilova |
|
No 1 (2001) |
Phthisiatric and pulmonologic tasks for tuberculosis detection in Russian children |
Abstract
PDF (Rus)
|
V. A. Aksenova |
|
No 1 (2001) |
An improvement of bronchial obstruction therapy in lung tuberculosis patients |
Abstract
PDF (Rus)
|
E. I. Shmelev, G. M. Kuklina |
|
No 1 (2001) |
Outpatient rehabilitation of chronic nonspecific pulmonary diseases patients in a anti-tuberculosis center |
Abstract
PDF (Rus)
|
E. E. Kalinina, N. A. Zhuk, A. A. Priymak |
|
No 1 (2001) |
An experience of treatment of pneumomycosis with Medoflucon |
Abstract
PDF (Rus)
|
G. V. Voyinova, S. A. Burova |
|
No 1 (2001) |
Ultrasonic examination in complex diagnostics of lung and pleura diseases |
Abstract
PDF (Rus)
|
V. I. Repik |
|
No 1 (2001) |
Early-stage lung cancer markers in liquidators of the Chernobyl accident |
Abstract
PDF (Rus)
|
S. Yu. Chlkina, I. D. Kopylev, M. V. Samsonova, A. L. Chenyaev, T. L. Pashkova, V. V. Chizhikov, I. B. Zborovskaya, A. G. Tatocyan, N. E. Chernekhovskaya, N. A. Glagolev, P. M. Kotlyarov, A. G. Chuchalin |
|
No 1 (2001) |
Evaluation of tumor growth markers in lung cancer patients |
Abstract
PDF (Rus)
|
I. E. Bakhlaev, E. K. Oleinik, A. I. Ageenko, V. M. Oleinik |
|
No 4 (2000) |
Laser therapy in pulmonology |
Abstract
PDF (Rus)
|
A. M. Shchegolkov, L. M. KIyachkin, V. P. Yaroshenko, I. L. KIyachkina |
|
No 4 (2000) |
An influence of bicycle training on lung function and lipid peroxidation in a complex treatment of pneumonia patients |
Abstract
PDF (Rus)
|
G. G. Efremushkin, T. A. Krymova |
|
No 4 (2000) |
Respiratory rehabilitation: a choice of methods and schedules |
Abstract
PDF (Rus)
|
E. K. Zilber |
|
No 4 (2000) |
Laser therapy for rehabilitation of bronchial asthma patients |
Abstract
PDF (Rus)
|
N. S. Ostronosova, V. N. Sapyorov, I. I. Andreeva |
|
No 4 (2000) |
Actual problems of modern physical therapy of bronchial asthma |
Abstract
PDF (Rus)
|
A. G. Malyavin |
|
No 4 (2000) |
Rehabilitation of patients with non-tuberculous lung diseases: our experience and a sight on the problem’s perspectives |
Abstract
PDF (Rus)
|
A. N. Kokosov |
|
No 4 (2000) |
Haloaerosol therapy in rehabilitation of respiratory patients |
Abstract
PDF (Rus)
|
A. V. Chervinskaya, A. N. Aleksandrov, G. V. Derpgolts, N. G. Stepanova |
|
No 4 (2000) |
Dynamics of psychological status of bronchial asthma patients at secondary prevention time |
Abstract
PDF (Rus)
|
E. I. Kuznetsova, I. V. Leshchenko, E. A. Medvedsky |
|
No 4 (2000) |
Modern approaches to mild and moderate bronchial asthma therapy in pediatrics |
Abstract
PDF (Rus)
|
O. V. Zaytseva, S. V. Zaytseva, G. A. Samsygina |
|
No 4 (2000) |
Psychological aspects of organization and training conduction at “Asthma-school” |
Abstract
PDF (Rus)
|
V. M. Provotorov, A. V. Budnevsky |
|
No 4 (2000) |
Efficacy of nebulized therapy for outpatient bronchial asthma exacerbation in children |
Abstract
PDF (Rus)
|
A. B. Malakhov, V. P. Zheludova, S. A. Makarova, E. G. Ryzhova |
|
No 4 (2000) |
Microbiological basis for economical outpatient antibacterial treatment of community acquired pneumonia |
Abstract
PDF (Rus)
|
M. B. Bogdanov, T. V. Chernenkaya |
|
No 4 (2000) |
Dynamics of quality of life in chronic obstructive bronchitis patients influenced by Salmeterol |
Abstract
PDF (Rus)
|
E. I. Shmelev, N. M. Shmeleva, N. A. Didkovsky, I. A. Malashenkova, M. V. Beda, N. M. Barmlcheyeva, A. A. Peresetsky |
|
No 3 (2000) |
An influence of smoke from wood fire on respiratory diseases course |
Abstract
PDF (Rus)
|
V. A. Dobrykh, L. G. Gonokhova, V. Yu. Tarasevich, S. V. Pichugina, A. F. Makhinova, V. A. Ryabkova |
|
No 3 (2000) |
Aiexithymia in a personality structure of bronchial asthma patients |
Abstract
PDF (Rus)
|
V. M. Provotorov, V. N. Krut’ko, A. V. Budnevsky, T. I. Grekova, V. I. Zoloedov, V. I. Ryaskin, S. V. Kharchevnikova |
|
No 3 (2000) |
Clinicaland-morphological peculiarities of acute pneumonia in infants with primary immune deficiency |
Abstract
PDF (Rus)
|
A. Yu. Pishchalnikov, R. U. Giniatullin, S. N. Teplova |
|
No 3 (2000) |
Changes in blood leukocytes corpuscular volume under respiratory diseases |
Abstract
PDF (Rus)
|
V. B. Matyushichev, V. G. Shamratova, D. A. Muzafarova |
|
No 3 (2000) |
Intrabronchial lymphotropic therapy of abscess-forming pneumonia |
Abstract
PDF (Rus)
|
N. E. Chernekhovskaya, I. V. Iarema, V. I. Vtorenko, V. K. Shishlo, V. G. Andreev, D. P. Cherepyantsev, G. G. Fedchenko |
|
No 3 (2000) |
The opportunity COPD patients’ life-expectancy prognosing in order to elaborate indications for lung grafting |
Abstract
PDF (Rus)
|
P. K. Yablonsky, N. I. Alexandrova, T. A. Fedorova, Yu. F. Neklasov, A. L. Alexandrov |
|
No 3 (2000) |
Extrapulmonary visceral pathology in bronchial asthma patients (clinical and morphological aspects) |
Abstract
PDF (Rus)
|
M. M. Kirillov, T. G. Shapovalova, M. M. Shashina, A. V. Bocharov, S. M. Kirillov, A. V. Lomonosov, S. B. Smolyak, A. Yu. Ryabova, O. G. Kazban, O. F. Kurnosova |
|
No 3 (2000) |
Comparative analysis of cooperation ‘factors for asthma patients |
Abstract
PDF (Rus)
|
N. A. Bushueva, N. Yu. Senkevich, A. S. Belevsky, A. G. Chuchalin |
|
No 3 (2000) |
Survival assessment in adult cystic fibrosis patients |
Abstract
PDF (Rus)
|
A. V. Cherniak, E. L. Amelina, N. Yu. Kashirskaya, N. I. Kapranov, A. L. Cherniaev, A. G. Chuchalin |
|
No 3 (2000) |
Tilade prophylaxis in children with the recurrent croup |
Abstract
PDF (Rus)
|
V. V. Karpov, L. A. Safronenko, N. L. Shapranova |
|
No 3 (2000) |
Efficacy of educational programme for COPD patients among residents of Gyandji town (Azerbaidjan) |
Abstract
PDF (Rus)
|
Kh. Yu. Guseinov |
|
No 3 (2000) |
An efficacy of Flixotid in atopic bronchial asthma patients |
Abstract
PDF (Rus)
|
Yu. O. Salikaeva, L. I. Volkova, E. A. Gereng, R. I. PIeshko, A. N. Poltoratsky, V. S. Bogomyagkov, S. S. Shakhova |
|
No 3 (2000) |
Pharmacoeconomics of outpatient treatment of lower airways infectious diseases |
Abstract
PDF (Rus)
|
Yu. B. Belousov, S. S. Shmat, T. G. Selevina, O. V. Efremenkova |
|
No 3 (2000) |
Lung surfaktant system and correction of its damage in bronchical and pulmonary siseases |
Abstract
PDF (Rus)
|
E. N. Nesterov, G. N. Panevskaya |
|
No 2 (2000) |
Analisis of diagnostic errors in lung pathology based on aytopsy data in Zheleznogorsk town |
Abstract
PDF (Rus)
|
A. E. Ali-Riza, A. L. Chernyaev, M. V. Samsonova, G. Ya. Melnikov, V. A. Kovrigin, E. V. Zhoga |
|
No 2 (2000) |
Impulse oscillometry and its possibilities in diagnostics of lung mechanics disorders |
Abstract
PDF (Rus)
|
L. D. Kiryukhina, V. K. Kuznetsova, E. S. Aganezova, N. G. Yakovleva, M. Yu. Kameneva |
|
No 2 (2000) |
Estimation of clinical efficiency of new Russian bronchodilating drugs in chronic obstructive bronchitis patients in the North |
Abstract
PDF (Rus)
|
A. F. Kolpakova |
|
No 2 (2000) |
Comparison of efficacy of Ingakort, Beclomethazone-easyhaler and Flixotide-diskus in their sequential administration for bronchial asthmatic patients |
Abstract
PDF (Rus)
|
A. N. Tsoy, F. I. Abazova, M. S. Gafurov, O. A. Shor |
|
No 2 (2000) |
Computed X-ray densitometry in lung emphysema diagnostics |
Abstract
PDF (Rus)
|
V. I. Nechaev |
|
No 2 (2000) |
Pharmacoepidemiology of out-patient pneumonia |
Abstract
PDF (Rus)
|
O. I. Karpov |
|
No 2 (2000) |
Peculiarities of spectral tussography in patients with bronchial asthma and diabetes |
Abstract
PDF (Rus)
|
V. M. Provotorov, L. V. Bilchenko, B. B. Romashov |
|
No 2 (2000) |
Step-by-step management of bronchial asthma children: step up or step down? |
Abstract
PDF (Rus)
|
V. I. Petrov, I. V. Smolenov, O. A. Alikova, N. A. Smirnov, F. I. Abazova |
|
No 2 (2000) |
Therapy of severe bronchial asthma attacks by nebulized Berodual |
Abstract
PDF (Rus)
|
G. L. Ignatova, D. G. Zharkova, T. A. Goncharova |
|
No 2 (2000) |
Clinical and pathogenic significance of purine metabolism in bronchial asthma patients |
Abstract
PDF (Rus)
|
A. K. Kurbanov |
|
No 2 (2000) |
Modern clinical-and-morphological characterization of acute purulent destructive lung diseases |
Abstract
PDF (Rus)
|
I. I. Dantsig, I. M. Skipsky, N. F. Lyovin |
|
No 2 (2000) |
Shifts in the content of nitric oxide in saliva of bronchial asthmatic patients under conditions of pulmonary hypertension formation |
Abstract
PDF (Rus)
|
E. Ye. Nazaretyan, M. Z. Narimanyan, T. V. Martirossyan, A. Yu. Gasparyan |
|
No 1 (2000) |
Rrepatative reactions in the lungs during treatment of experimental granulomatosis (sarcoidosis) |
Abstract
PDF (Rus)
|
L. E. Guedymin, V. V. Erokhin, L. N. Lepekha, M. B. Golant, D. M. Belyaev, L. Z. Balakireva, T. V. Kolpikova |
|
No 1 (2000) |
Peculiarities of sarcoidosis course in patients with persistence of granular mycobacteria |
Abstract
PDF (Rus)
|
L. V. Ozerova, S. G. Safonova, N. P. Rybakova, L. G. Guedymin, V. V. Romanov, I. P. Zaitseva, O. N. Shemetoun |
|
No 1 (2000) |
Ciliary activity of ciliated epithelium cells in patients with lower airway infection (pneumonia and acute bronchitis) |
Abstract
PDF (Rus)
|
A. L. Rakov, D. N. Panfilov, B. I. Gueltser |
|
No 1 (2000) |
Emoxypyne in treatment of patients with bronchial asthma |
Abstract
PDF (Rus)
|
S. V. Lapik, V. A. Zhmurov, T. V. Popova |
|
No 1 (2000) |
Nitric oxide in the exhaled air |
Abstract
PDF (Rus)
|
E. V. Babarskov, A. G. Chuchalin, Z. R. Aisanov |
|
No 1 (2000) |
Actual problems of respiratory tuberculosis: epidemiology, diagnosis, clinical features, treatment |
Abstract
PDF (Rus)
|
V. I. Repik, V. I. Chukhanov |
|
No 1 (2000) |
Cough and its treatment with the new peripherally-acting drug Levopront |
Abstract
PDF (Rus)
|
N. A. Kolganova, G. L. Osipova |
|
No 1 (2000) |
High resolution computed tomography in diagnosing of some disseminated and diffuse lung injuries |
Abstract
PDF (Rus)
|
V. I. Repik, M. V. Khroupenkova-Piven |
|
No 1 (2000) |
Detection of oncological risk groups in infiltrative lung tuberculosis patients |
Abstract
PDF (Rus)
|
O. K. Malysheva, N. U. Shniguer, A. A. Molodyk |
|
No 1 (2000) |
E oxygen-dependent metabolism and synthesis of thrombocytes activation factor and different types of guinea-pigs phagocytizing cells during natural trend of experimental tuberculosis and in specific chemotherapy conditions |
Abstract
PDF (Rus)
|
G. O. Kaminskaya, R. Yu. Abdullaev |
|
No 1 (2000) |
Determination of genetic markers for prediction of lung tuberculosis severity |
Abstract
PDF (Rus)
|
A. M. Ubaydullaev, K. S. Kazakov, R. B. Chernic, Sh. M. Saidova |
|
No 1 (2000) |
The inhaled steroid Ingakort in complex therapy of infiltrative lung tuberculosis |
Abstract
PDF (Rus)
|
A. A. Vizel, M. F. Yaushev, I. N. Khalfiev, I. N. Papkova |
|
1 - 200 of 1660 Items |
1 2 3 4 5 6 7 8 9 > >>
|